Evidence map›Paper›PMID 35086541›Full record

ArticleBMC complementary medicine and therapies2022

Extracts of Sida cordifolia contain polysaccharides possessing immunomodulatory activity and rosmarinic acid compounds with antibacterial activity.

Haroon Iqbal, Claire L Wright, Sue Jones, Goncalo Rosas da Silva, John McKillen, Brendan F Gilmore, Owen Kavanagh, Brian D Green

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Plants (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Article
  5. Current pharmaceutical biotechnology · 2024
    Review
  6. Article
  7. Microorganisms · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Haroon IqbalInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5AG, UK.
Claire L WrightSchool of Science, Health & Technology, York St John University, York, YO31 7EX, UK.
Sue JonesSchool of Science, Health & Technology, York St John University, York, YO31 7EX, UK.
Goncalo Rosas da SilvaInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5AG, UK.
John McKillenVeterinary Science Division, Agri-Food and Biosciences Institute, Stormont, Belfast, BT4 3SD, UK.
Brendan F GilmoreSchool of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, UK.
Owen KavanaghSchool of Science, Health & Technology, York St John University, York, YO31 7EX, UK.
Brian D GreenInstitute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Belfast, BT9 5AG, UK. b.green@qub.ac.uk.
Queen's University Belfast · GBYork St John University · GBAgri Food and Biosciences Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe overuse of antibiotics has led to increased antimicrobial resistance, but plant-derived biological response modifiers represent a potential alternative to these drugs. This investigation examined the immunomodulatory and antibacterial activities of Sida cordifolia (used in ethnomedicinal systems to treat infectious disease).

methodsSuccessive extractions were performed from the roots of these plants in hexane, chloroform, methanol and water. Immunomodulatory activity was determined in a series of experiments measuring the responses of splenocytes, macrophages and an in vivo model of innate immunity (Galleria mellonella). Antibacterial activity was assessed by determining minimum inhibitory/bactericidal concentrations (MIC/MBCs) for various Gram-positive and Gram-negative bacterial strains.

resultsImmunomodulatory activity was confined to the aqueous extract, and further fractionation and biochemical analysis yielded a highly potent polysaccharide-enriched fraction (SCAF5). SCAF5 is a complex mixture of different polysaccharides with multiple immunomodulatory effects including immune cell proliferation, antibody secretion, phagocytosis, nitric oxide production, and increased expression of pro-inflammatory cytokines. Furthermore, Galleria mellonella pre-treated with SCAF5 produced more haemocytes and were more resistant (P < 0.001) to infection with methicillin-resistant Staphylococcus aureus (MRSA) with a 98% reduction in bacterial load in pre-treated larvae compared to the negative control. The antibacterial activity of Sida cordifolia was confined to the methanolic fraction. Extensive fractionation identified two compounds, rosmarinic acid and its 4-O-β-d-glucoside derivative, which had potent activity against Gram-positive antibiotic-resistant bacteria, including MRSA.

conclusionsSida cordifolia counters bacterial infections through a dual mechanism, and immunomodulatory polysaccharides from this plant should be isolated and characterised to realise their potential as anti-infective agents. Such properties could be developed as an antibiotic alternative (1) in the clinic and (2) alternative growth promoter for the agri-food industry.

Indexed as

AnimalsAnti-Bacterial AgentsCinnamatesDepsidesDrug Resistance, BacterialFemaleGram-Negative BacteriaGram-Positive BacteriaImmunologic FactorsLarvaMalvaceaeMedicine, TraditionalMethicillin-Resistant Staphylococcus aureusMiceMice, Inbred BALB CMothsAnti-Bacterial AgentsCinnamatesDepsidesImmunologic FactorsPlant ExtractsPolysaccharidesRosmarinic AcidAntibiotic alternativeAntibiotic resistanceAntimicrobialFeed supplementGalleria mellonellaImmunomodulationImmunostimulantPlant-derived biological response modifiersPolysaccharidesRosmarinic acidSida cordifolia

Identifiers

PMID35086541
PMCPMC8793188
OpenAlexW4221038645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.